Skip to main content
Top

PharmacoEconomics

Issue 9/2006

Content (10 Articles)

Editorial

US FDA Guidance

Paul Kind

Current Opinion

The Value of Thinly Spread QALYs

Duncan Mortimer

Review Article

Cost-of-Illness Studies

Ebere Akobundu, Jing Ju, Lisa Blatt, C. Daniel Mullins

Original Research Article

Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003

Yue-Chune Lee, Ming-Chin Yang, Yu-Tung Huang, Chien-Hsiang Liu, Sun-Bing Chen

Original Research Article

Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia

John H. Wlodarczyk, Leslie G. Cleland, Anne M. Keogh, Keith D. McNeil, Kate Perl, Robert G. Weintraub, Trevor J. Williams

Original Research Article

Missing Data Imputation in Quality-of-Life Assessment

Ting Hsiang Lin

Correspondence

The Authors’ Reply

Adrian A. Bagust, Marc Evans, Sophie Beale, Philip Home, Andrew Perry, Murray Stewart, Arran Shearer, Alan Martin, Lisa Hulme, Andreas Liebl, Oliver Schoeffski, Anita Goertz, Javier Ampudia-Blasco, Belen Martinez-Lage, Isabel Perez Escolano, Gonzalo Paris